Best KdT Ventures Podcasts (2025)

1
The World in a Grain of Sand: BioAge 33:43

5M ago33:43

33:43

KdT Ventures presents The World in a Grain of Sand, where we break down an S1 from a recent biotech IPO and share insights on the science, business models, and financials. In this episode, Cain McClary and Phil Grayeski discuss BioAge, a longevity biotech with a pipeline of therapies for diseases of aging including cardiometabolic disease and neuro…

1
The World in a Grain of Sand: CG Oncology 43:43

12M ago43:43

43:43

KdT Ventures presents The World in a Grain of Sand, where we break down an S1 from a recent biotech IPO and share insights on the science, business models, and financials. In this episode, Cain McClary and Phil Grayeski discuss CG Oncology, the first biotech IPO of 2024. We dive into: The various subtypes of bladder cancer, and one of the most uniq…

1
The World in a Grain of Sand: Verve Therapeutics 41:27

1y ago41:27

41:27

KdT Ventures presents The World in a Grain of Sand, where we break down an S1 from a recent biotech IPO and share insights on the science, business models, and financials. In this episode, Ketan Yerneni and Mack Healy discuss Verve Therapeutics, a gene editing biotech tackling one of the most common chronic diseases: cardiovascular disease. We dive…

1
The World in a Grain of Sand: Schrödinger 42:16

1+ y ago42:16

42:16

KdT Ventures presents The World in a Grain of Sand, where we break down an S1 from a recent biotech IPO and share insights on the science, business models, and financials. In this episode, Patrick Malone and Mack Healy discuss the biopharma software juggernaut, Schrödinger. We dive into: Schrödinger's biophysics-based drug discovery platform, and t…

1
The World in a Grain of Sand: Amylyx Pharmaceuticals 34:33

2y ago34:33

34:33

KdT Ventures Partners, Mack Healy & Rima Chakrabarti take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This episode, Amylyx Pharmaceuticals, a neuro biotech founded in a dorm room by two scrappy Brown undergrads. We discuss: the mechanism of action of Amylyx’s lead disease-modify…

1
The World in a Grain of Sand: Codiak BioSciences 37:15

2y ago37:15

37:15

KdT Ventures Partners, Mack Healy & Phil Grayeski take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Codiak BioSciences.

1
The World in a Grain of Sand: Royalty Pharma 39:49

2+ y ago39:49

39:49

KdT Ventures Partners, Mack Healy & Cain McClary take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Royalty Pharma.

1
The World in a Grain of Sand: Sana Biotechnology 37:03

2+ y ago37:03

37:03

KdT Ventures Partners, Mack Healy & Phil Grayeski take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Sana Biotechnology.

1
The World in a Grain of Sand: Editas 39:05

3y ago39:05

39:05

KdT Ventures Partners, Mack Healy & Cain McClary take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Editas.

1
The World in a Grain of Sand: Century Therapeutics 41:41

3y ago41:41

41:41

KdT Ventures Partners, Mack Healy & Rima Chakrabarti take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Century Therapeutics.

1
The World In A Grain of Sand: Taysha 30:24

3y ago30:24

30:24

The KdT Ventures team takes a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Taysha GTx

1
The World In A Grain of Sand: Atai 40:19

3+ y ago40:19

40:19

The KdT Ventures team takes a deep dive into a specific S-1 filing from a company that is hoping to go public within the biology realm. This month, Atai

1
The World In A Grain of Sand: Recursion Pharmaceuticals 40:25

4y ago40:25

40:25

The KdT Ventures team takes a deep dive into a specific S-1 filing from a company that is hoping to go public within the biology realm. This month, Recursion Pharmaceuticals.

1
The World In A Grain of Sand: AbCellera 42:55

4y ago42:55

42:55

The KdT Ventures team takes a deep dive into a specific S-1 filing from a company that is hoping to go public within the biology realm. This month, AbCellera.

Podcasts Worth a Listen

KdT Ventures Podcasts

Podcasts Worth a Listen

1
The World In A Grain Of Sand

KdT Ventures

1
The World in a Grain of Sand: BioAge 33:43

1
The World in a Grain of Sand: CG Oncology 43:43

1
The World in a Grain of Sand: Verve Therapeutics 41:27

1
The World in a Grain of Sand: Schrödinger 42:16

1
The World in a Grain of Sand: Amylyx Pharmaceuticals 34:33

1
The World in a Grain of Sand: Codiak BioSciences 37:15

1
The World in a Grain of Sand: Royalty Pharma 39:49

1
The World in a Grain of Sand: Sana Biotechnology 37:03

1
The World in a Grain of Sand: Editas 39:05

1
The World in a Grain of Sand: Century Therapeutics 41:41

1
The World In A Grain of Sand: Taysha 30:24

1
The World In A Grain of Sand: Atai 40:19

1
The World In A Grain of Sand: Recursion Pharmaceuticals 40:25

1
The World In A Grain of Sand: AbCellera 42:55

Quick Reference Guide